COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Tóm tắt
Từ khóa
Tài liệu tham khảo
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5
World Health Organization
Xiong, 2020, Coronaviruses and the cardiovascular system: acute and long-term implications, Eur Heart J, 41, 1798, 10.1093/eurheartj/ehaa231
Clerkin, 2020, Coronavirus disease 2019 (COVID-19) and cardiovascular disease, Circulation
Driggin, 2020, Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic, J Am Coll Cardiol, 75, 2352, 10.1016/j.jacc.2020.03.031
Madjid, 2020, Potential effects of coronaviruses on the cardiovascular system: a review, JAMA Cardiol, 10.1001/jamacardio.2020.1286
Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 18, 844, 10.1111/jth.14768
Fan, 2020, Hematologic parameters in patients with COVID-19 infection, Am J Hematol
Lew, 2003, Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome, JAMA, 290, 374, 10.1001/jama.290.3.374
Madjid, 2004, Influenza and cardiovascular disease: is there a causal relationship?, Tex Heart Inst J, 31, 4
Kearon, 2016, Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report, Chest, 149, 315, 10.1016/j.chest.2015.11.026
Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058
Zhang, 2020, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Intensive Care Med, 46, 586, 10.1007/s00134-020-05985-9
van Doremalen, 2020, Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N Engl J Med, 382, 1564, 10.1056/NEJMc2004973
Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7
Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585
Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 10.1056/NEJMoa2002032
Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention, JAMA, 10.1001/jama.2020.2648
Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, 10.1001/jamainternmed.2020.0994
Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3
Libby, 2001, Inflammation and thrombosis: the clot thickens, Circulation, 103, 1718, 10.1161/01.CIR.103.13.1718
Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis, Clin Chim Acta, 506, 145, 10.1016/j.cca.2020.03.022
Lippi, 2020, D-dimer is associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis, Thromb Haemost
Han, 2020, Prominent changes in blood coagulation of patients with SARS-CoV-2 infection, Clin Chem Lab Med, 10.1515/cclm-2020-0188
Lippi, 2020, Laboratory abnormalities in patients with COVID-2019 infection, Clin Chem Lab Med, 10.1515/cclm-2020-0198
Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5
Gao, 2020, Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19, J Med Virol, 10.1002/jmv.25770
Lippi, 2010, Shortened activated partial thromboplastin time: causes and management, Blood Coagul Fibrinolysis, 21, 459, 10.1097/MBC.0b013e328338dbe8
Levi, 2009, Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology, Br J Haematol, 145, 24, 10.1111/j.1365-2141.2009.07600.x
Borges, 2014, Factors associated with D-dimer levels in HIV-infected individuals, PLoS One, 9, 10.1371/journal.pone.0090978
Ramacciotti, 2019, Zika and chikungunya virus and risk for venous thromboembolism, Clin Appl Thromb Hemost, 25, 10.1177/1076029618821184
Smither, 2019, Haemostatic changes in five patients infected with ebola virus, Viruses, 11, 647, 10.3390/v11070647
Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0
Zhang, 2020, Liver injury in COVID-19: management and challenges, Lancet Gastroenterol Hepatol, 5, 428, 10.1016/S2468-1253(20)30057-1
Zhang, 2020, Coagulopathy and antiphospholipid antibodies in patients with Covid-19, N Engl J Med, 382, e38, 10.1056/NEJMc2007575
Lippi, 2020, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis, Prog Cardiovasc Dis, 10.1016/j.pcad.2020.03.001
Januzzi
Thygesen, 2018, Fourth Universal Definition of Myocardial Infarction (2018), J Am Coll Cardiol, 72, 2231, 10.1016/j.jacc.2018.08.1038
Totzeck, 2017, Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta-analysis of more than 20,000 patients, J Am Heart Assoc, 6
Economopoulou, 2015, Cancer therapy and cardiovascular risk: focus on bevacizumab, Cancer Manag Res, 7, 133, 10.2147/CMAR.S77400
Zhu, 2015, Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial, Circulation, 132, 1104, 10.1161/CIRCULATIONAHA.115.016371
Olsen, 2013, Multifaceted effects of hydroxychloroquine in human disease, Semin Arthritis Rheum, 43, 264, 10.1016/j.semarthrit.2013.01.001
2011
2011
Itkonen, 2019, Clopidogrel increases dasabuvir exposure with or without ritonavir, and ritonavir inhibits the bioactivation of clopidogrel, Clin Pharmacol Ther, 105, 219, 10.1002/cpt.1099
Marsousi, 2018, Impact of boosted antiretroviral therapy on the pharmacokinetics and efficacy of clopidogrel and prasugrel active metabolites, Clin Pharmacokinet, 57, 1347, 10.1007/s40262-018-0637-6
Rogers, 2012, Triggers of hospitalization for venous thromboembolism, Circulation, 125, 2092, 10.1161/CIRCULATIONAHA.111.084467
Konstantinides, 2020, 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS), Eur Heart J, 41, 543, 10.1093/eurheartj/ehz405
Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103
Leizorovicz, 2004, Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients, Circulation, 110, 874, 10.1161/01.CIR.0000138928.83266.24
Cohen, 2006, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, 332, 325, 10.1136/bmj.38733.466748.7C
Schunemann, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients, Blood Adv, 2, 3198, 10.1182/bloodadvances.2018022954
Kahn, 2012, Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e195S, 10.1378/chest.11-2296
Albertsen, 2018, Searching for high-risk venous thromboembolism patients using risk scores: adding to the heap or closing a gap?, Thromb Haemost, 118, 1686, 10.1055/s-0038-1673330
Barbar, 2010, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J Thromb Haemost, 8, 2450, 10.1111/j.1538-7836.2010.04044.x
Arcelus, 1991, Venous thromboembolism prophylaxis and risk assessment in medical patients, Semin Thromb Hemost, 17, 313
Liu, 2016, Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study, Interact Cardiovasc Thorac Surg, 23, 538, 10.1093/icvts/ivw158
Rosenberg, 2014, External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system, J Am Heart Assoc, 3
Spyropoulos, 2011, Predictive and associative models to identify hospitalized medical patients at risk for VTE, Chest, 140, 706, 10.1378/chest.10-1944
Wang, 2020, Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19, Lancet Haematol, 10.1016/S2352-3026(20)30109-5
Hunt, 2018, Hemostasis at extremes of body weight, Semin Thromb Hemost, 44, 632, 10.1055/s-0038-1661385
Ho, 2013, Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients, Circulation, 128, 1003, 10.1161/CIRCULATIONAHA.113.002690
Popoola, 2017, Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention, Thromb Res, 160, 109, 10.1016/j.thromres.2017.10.012
Bates, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy, Blood Adv, 2, 3317, 10.1182/bloodadvances.2018024802
Ikesaka, 2014, Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: a systematic review and meta-analysis, Thromb Res, 133, 682, 10.1016/j.thromres.2014.01.021
Hull, 2010, Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial, Ann Intern Med, 153, 8, 10.7326/0003-4819-153-1-201007060-00004
Cohen, 2016, Extended thromboprophylaxis with betrixaban in acutely ill medical patients, N Engl J Med, 375, 534, 10.1056/NEJMoa1601747
Cohen, 2013, Rivaroxaban for thromboprophylaxis in acutely ill medical patients, N Engl J Med, 368, 513, 10.1056/NEJMoa1111096
Spyropoulos, 2018, Rivaroxaban for thromboprophylaxis after hospitalization for medical illness, N Engl J Med, 379, 1118, 10.1056/NEJMoa1805090
Spyropoulos, 2020, Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis, TH Open, 4, e59, 10.1055/s-0040-1705137
Dentali, 2017, Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials, Thromb Haemost, 117, 606, 10.1160/TH16-08-0595
Schindewolf, 2020, Broadening the categories of patients eligible for extended venous thromboembolism treatment, Thromb Haemost, 120, 14, 10.1055/s-0039-3400302
Spyropoulos, 2019, Improved benefit risk profile of rivaroxaban in a subpopulation of the MAGELLAN study, Clin Appl Thromb Hemost, 25, 10.1177/1076029619886022
Cohen, 2014, D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial, J Thromb Haemost, 12, 479, 10.1111/jth.12515
Bikdeli, 2018, Early use of echocardiography in patients with acute pulmonary embolism: findings from the RIETE registry, J Am Heart Assoc, 7
Obi, 2019, Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients, J Vasc Surg Venous Lymphat Disord, 7, 317, 10.1016/j.jvsv.2018.08.010
Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res
Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost
Xie, 2020, COVID-19 complicated by acute pulmonary embolism, Radiol Cardiothorac Imaging, 2, 10.1148/ryct.2020200067
Danzi, 2020, Acute pulmonary embolism and COVID-19 pneumonia: a random association?, Eur Heart J, 41, 1858, 10.1093/eurheartj/ehaa254
Cui, 2020, Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia, J Thromb Haemost, 10.1111/jth.14830
Witt, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, Blood Adv, 2, 3257, 10.1182/bloodadvances.2018024893
Jaff, 2011, Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association, Circulation, 123, 1788, 10.1161/CIR.0b013e318214914f
Reza, 2015, Pulmonary embolism response teams, Curr Treat Options Cardiovasc Med, 17, 27, 10.1007/s11936-015-0387-9
Barnes, 2016, Diversity in the pulmonary embolism response team model: an organizational survey of the National PERT Consortium Members, Chest, 150, 1414, 10.1016/j.chest.2016.09.034
Rosovsky, 2019, Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions, Res Pract Thromb Haemost, 3, 315, 10.1002/rth2.12216
Giri, 2019, Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association, Circulation, 140, e774, 10.1161/CIR.0000000000000707
Chatterjee, 2014, Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis, JAMA, 311, 2414, 10.1001/jama.2014.5990
Bikdeli, 2017, Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis, J Am Coll Cardiol, 70, 1587, 10.1016/j.jacc.2017.07.775
Jimenez, 2018, Aggressive treatment of intermediate-risk patients with acute symptomatic pulmonary embolism, Clin Chest Med, 39, 569, 10.1016/j.ccm.2018.04.011
Ain, 2018, Extra-corporeal membrane oxygenation and outcomes in massive pulmonary embolism: Two eras at an urban tertiary care hospital, Vasc Med, 23, 60, 10.1177/1358863X17739697
Vedantham, 2017, Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis, N Engl J Med, 377, 2240, 10.1056/NEJMoa1615066
Kwong, 2018, Acute myocardial infarction after laboratory-confirmed influenza infection, N Engl J Med, 378, 345, 10.1056/NEJMoa1702090
Corrales-Medina, 2010, Role of acute infection in triggering acute coronary syndromes, Lancet Infect Dis, 10, 83, 10.1016/S1473-3099(09)70331-7
Amsterdam, 2014, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 130, 2354, 10.1161/CIR.0000000000000133
O'Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019
Welt, 2020, Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI, J Am Coll Cardiol, 75, 2372, 10.1016/j.jacc.2020.03.021
Zeng, 2020, How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital, Intensive Care Med, 10.1007/s00134-020-05993-9
Cook, 2000, Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients, J Crit Care, 15, 127, 10.1053/jcrc.2000.19224
Minet, 2015, Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis, Crit Care, 19, 287, 10.1186/s13054-015-1003-9
Geerts, 2003, Prevention of venous thromboembolism in the ICU, Chest, 124, 357s, 10.1378/chest.124.6_suppl.357S
Crowther, 2002, Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study, Blood Coagul Fibrinolysis, 13, 49, 10.1097/00001721-200201000-00007
Smith, 2012, Introduction to drug pharmacokinetics in the critically iii patient, Chest, 141, 1327, 10.1378/chest.11-1396
Sklar, 2016, Anticoagulation practices during venovenous extracorporeal membrane oxygenation for respiratory failure. a systematic review, Ann Am Thorac Soc, 13, 2242, 10.1513/AnnalsATS.201605-364SR
2017
Stockmann, 2014, Therapeutic temperature management after cardiac arrest and the risk of bleeding: systematic review and meta-analysis, Resuscitation, 85, 1494, 10.1016/j.resuscitation.2014.07.018
Hunt, 2014, Bleeding and coagulopathies in critical care, N Engl J Med, 370, 847, 10.1056/NEJMra1208626
Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786
Wada, 2013, Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from 3 guidelines, J Thromb Haemost, 10.1111/jth.12155
Aujesky, 2011, Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial, Lancet, 378, 41, 10.1016/S0140-6736(11)60824-6
Zondag, 2013, Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis, Eur Respir J, 42, 134, 10.1183/09031936.00093712
Barco, 2020, Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial, Eur Heart J, 41, 509, 10.1093/eurheartj/ehz367
Schulman, 2011, Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial, Ann Intern Med, 155, 10.7326/0003-4819-155-10-201111150-00003
Han, 2020, CSC Expert consensus on principles of clinical management of patients with severe emergent cardiovascular diseases during the COVID-19 epidemic, Circulation, 10.1161/CIRCULATIONAHA.120.047011
Stefanini, 2020, Critical organizational issues for cardiologists in the COVID-19 outbreak: a frontline experience from Milan, Italy, Circulation, 10.1161/CIRCULATIONAHA.120.047070
Kluge, 2020
2020
2020
2020
Engbers, 2017, Functional impairment and risk of venous thrombosis in older adults, J Am Geriatr Soc, 65, 2003, 10.1111/jgs.14964
Kabrhel, 2011, Physical inactivity and idiopathic pulmonary embolism in women: prospective study, BMJ, 343, d3867, 10.1136/bmj.d3867
Lutsey, 2010, Correlates and consequences of venous thromboembolism: the Iowa Women's Health Study, Am J Public Health, 100, 1506, 10.2105/AJPH.2008.157776
Bikdeli, 2012, When the game demons take real lives: a call for global awareness raising for venous thromboembolism, Thromb Res, 129, 207, 10.1016/j.thromres.2011.09.034
Beasley, 2003, eThrombosis: the 21st century variant of venous thromboembolism associated with immobility, Eur Respir J, 21, 374, 10.1183/09031936.03.00039403
2020
Kort, 2017, Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study, J Thromb Haemost, 15, 2352, 10.1111/jth.13868
Isma, 2013, Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up, J Thromb Thrombolysis, 36, 58, 10.1007/s11239-012-0858-8
Bikdeli, 2018, Rationale, design and methodology of the computerized registry of patients with venous thromboembolism (RIETE), Thromb Haemost, 118, 214, 10.1160/TH17-07-0511
Chong, 2004, Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis, Arch Pathol Lab Med, 128, 195, 10.5858/2004-128-195-AODDTS
Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5
Tsui, 2005, Coronary plaque instability in severe acute respiratory syndrome, Int J Cardiol, 99, 471, 10.1016/j.ijcard.2003.11.052
Umapathi, 2004, Large artery ischaemic stroke in severe acute respiratory syndrome (SARS), J Neurol, 251, 1227
Wong, 2003, Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis, BMJ, 326, 1358, 10.1136/bmj.326.7403.1358
Zhou, 2013, Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis, J Infect Dis, 209, 1331, 10.1093/infdis/jit504
Li, 2016, Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4, J Infect Dis, 213, 712, 10.1093/infdis/jiv499
2013, State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans, PLoS Curr, 5
Dimakakos, 2016, H1N1-induced venous thromboembolic events? results of a single-institution case series, Open Forum Infect Dis, 3, ofw214, 10.1093/ofid/ofw214
Bunce, 2011, Pandemic H1N1 influenza infection and vascular thrombosis, Clin Infect Dis, 52, e14, 10.1093/cid/ciq125
Naghavi, 2003, Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice, Circulation, 107, 762, 10.1161/01.CIR.0000048190.68071.2B
Zhu, 2009, Association of influenza vaccination with reduced risk of venous thromboembolism, Thromb Haemost, 102, 1259, 10.1160/TH09-04-0222
Smeeth, 2004, Risk of myocardial infarction and stroke after acute infection or vaccination, N Engl J Med, 351, 2611, 10.1056/NEJMoa041747
Warren-Gash, 2012, Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study, J Infect Dis, 206, 1652, 10.1093/infdis/jis597
Davison, 1973, Intravascular coagulation complicating influenza A virus infection, Br Med J, 1, 654, 10.1136/bmj.1.5854.654
Talley, 1971, Disseminated intravascular clotting complicating viral pneumonia due to influenza, Med J Aust, 2, 763, 10.5694/j.1326-5377.1971.tb92529.x
Whitaker, 1974, Disseminated intravascular coagulation and acute renal failure in influenza A2 infection, Med J Aust, 2, 196, 10.5694/j.1326-5377.1974.tb70703.x
Zhao, 2020, Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov, bioRxiv